Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium

Cell Commun Adhes. 2015 Apr-Dec;22(2-6):67-78. doi: 10.1080/15419061.2016.1225196. Epub 2016 Sep 7.

Abstract

Advanced glycation end-products (AGEs) are involved in the development of vascular smooth muscle cell (VSMC) dysfunction and the progression of atherosclerosis. However, AGEs may indirectly affect VSMCs via AGEs-induced signal transduction between monocytes and human umbilical endothelial cells (HUVECs), rather than having a direct influence. This study was designed to elucidate the signaling pathway underlying AGEs-RAGE axis influence on VSMC dysfunction using a co-culture system with monocytes, HUVECs and VSMCs. AGEs stimulated production of reactive oxygen species and pro-inflammatory mediators such as tumor necrosis factor-α and interleukin-1β via extracellular-signal-regulated kinases phosphorylation and nuclear factor-κB activation in HUVECs. It was observed that AGEs-induced pro-inflammatory cytokines increase VSMC proliferation, inflammation and vascular remodeling in the co-culture system. This result implies that RAGE plays a role in AGEs-induced VSMC dysfunction. We suggest that the regulation of signal transduction via the AGEs-RAGE axis in the endothelium can be a therapeutic target for preventing atherosclerosis.

Keywords: Advanced glycation end-products; inflammatory cytokines; reactive oxygen species; vascular dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaldehyde / analogs & derivatives
  • Acetaldehyde / metabolism
  • Coculture Techniques
  • Endothelium / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Glycation End Products, Advanced / metabolism*
  • Human Umbilical Vein Endothelial Cells / metabolism*
  • Humans
  • Inflammation / metabolism
  • Monocytes / metabolism
  • Muscle, Smooth, Vascular / metabolism*
  • Reactive Oxygen Species / metabolism*
  • Receptor for Advanced Glycation End Products
  • Signal Transduction / drug effects

Substances

  • Glycation End Products, Advanced
  • Reactive Oxygen Species
  • Receptor for Advanced Glycation End Products
  • Extracellular Signal-Regulated MAP Kinases
  • Acetaldehyde
  • glycolaldehyde